Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec 15;204(12):1363-1365.
doi: 10.1164/rccm.202109-2146ED.

New Insights into the Limitations of Host Transcriptional Biomarkers of Tuberculosis

Mahdad Noursadeghi  1 , Rishi K Gupta  2
Affiliations
Editorial

New Insights into the Limitations of Host Transcriptional Biomarkers of Tuberculosis

Mahdad Noursadeghi et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Venn diagram showing proportions of RISK11-positive participants in the HIV-negative cohort coenrolled in the CORTIS trial who had evidence of viral infection or prevalent or incident TB. Data are derived from Mulenga and colleagues (11). CORTIS = Correlate of Risk Targeted Intervention Study; TB = tuberculosis.
See this image and copyright information in PMC

Comment on

  • Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis.
    Mulenga H, Musvosvi M, Mendelsohn SC, Penn-Nicholson A, Kimbung Mbandi S, Fiore-Gartland A, Tameris M, Mabwe S, Africa H, Bilek N, Kafaar F, Khader SA, Carstens B, Hadley K, Hikuam C, Erasmus M, Jaxa L, Raphela R, Nombida O, Kaskar M, Nicol MP, Mbhele S, Van Heerden J, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Walzl G, Naidoo K, Churchyard G, Hatherill M, Scriba TJ; CORTIS Study Team. Mulenga H, et al. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1463-1472. doi: 10.1164/rccm.202103-0548OC. Am J Respir Crit Care Med. 2021. PMID: 34520313 Free PMC article.

References

    1. World Health Organization. https://www.who.int/teams/global-tuberculosis-programme/the-end-tb-strategy
    1. Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, et al. PREDICT Study Team. Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study. Lancet Infect Dis . 2018;18:1077–1087. - PMC - PubMed
    1. Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M, et al. The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One . 2011;6:e17984. - PMC - PubMed
    1. Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Aichelburg MC, et al. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med . 2020;26:1941–1949. - PMC - PubMed
    1. Haas CT, Roe JK, Pollara G, Mehta M, Noursadeghi M. Diagnostic ‘omics’ for active tuberculosis. BMC Med . 2016;14:37. - PMC - PubMed